NIH Funding Opportunities (Notices, PA, RFA)

Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 36 min 3 sec ago
Notice of Special Interest (NOSI): Administrative Supplements to STTR Regional Technology Transfer Accelerator Hubs to Provide Instruction in Business Fundamentals to Core Facility Directors
Notice NOT-GM-21-017 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp Clinical Trial Optional)
Notice NOT-MH-21-150 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Notice NOT-NS-21-031 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Notice NOT-NS-21-032 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Lung Transplant Consortium - Data Coordinating Center (U24 - Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-22-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to serve as the Data Coordinating Center (DCC) that will support the activities of the Lung Transplant Consortium (LTC). The primary responsibility of the DCC will be to oversee the conduct of multiple observational clinical studies involving lung transplantation in the LTC. The DCC will support regulatory and administrative activities, data and biospecimen collection and management, statistical analyses, and the reporting of study results in a timely manner. The DCC will promote collaboration and communication among LTC investigators and the broader research community and will coordinate outreach activities including engaging foundations, societies, and other entities with a shared interest in lung transplantation. The DCC will be responsible for integrating the efforts of approximately 24 individual LTC Clinical Centers performing observational research studies to identify factors that impact donor lung utilization and the development of acute lung allograft dysfunction in lung transplant recipients. The NHLBI anticipates that the DCC will collaborate strategically with the LTC Clinical Centers to provide support for protocol development, statistical data analyses, biospecimen collection and storage, the publication of results, and providing datasets for secondary analyses by the broader research community. This FOA runs in parallel with a separate FOA that invites applications for the LTC Clinical Centers, described in detail in RFA-HL-22-002
Categories: Job Watch, Literature Watch
Lung Transplant Consortium - Clinical Centers (U01 - Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-22-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks applications from lung transplant clinical centers (CCs) to form a cooperative multi-site Lung Transplant Consortium (LTC). The LTC will support CCs in conducting observational and complementary mechanistic clinical research studies that aim to understand the impact of site-specific lung transplant selection criteria and clinical management strategies on donor lung utilization and/or early post-transplant outcomes such as the development of primary graft dysfunction (PGD) and acute lung allograft dysfunction (ALAD) in recipients. Each CC application must consist of a multidisciplinary investigative team that includes a lung transplant surgeon and a lung transplant pulmonologist, and be comprised of primary and subsites that have a combined annual lung transplant volume of at least 100 transplants. Each CC application should propose hypothesis-driven scientific questions to assess certain donor and/or recipient clinical practices and their impact on donor lung utilization, PGD, ALAD or other relevant short-term outcomes that can be addressed through observational data and/or biospecimen collection and analysis at the sites included in their application. In addition, the CCs will be expected to enroll participants and contribute to a core set of data and biospecimens to be collected across all participating consortium sites through the implementation of a common research protocol under the auspices of a centralized Data Coordinating Center (DCC) and a Steering Committee (SC). By leveraging this shared longitudinal resource, LTC investigators will have the tools to identify and answer additional important research questions involving lung transplantation. This FOA runs in parallel with a separate FOA that invites applications for the LTC Data Coordinating Center, solicited under RFA-HL-22-003.
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
Notice NOT-GM-21-019 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2) (Clinical Trials Not Allowed)
Notice NOT-AR-21-014 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases and Sjogrens Syndrome (UC2 Clinical
Notice NOT-AR-21-013 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Request for Proposals (RFP) Notice: Development and Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorders
Notice NOT-DA-21-031 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Information: Submission of NIAID Investigator-Initiated Clinical Trials to Appropriate FOAs
Notice NOT-AI-21-037 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Award Information in PAR-20-108, "International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
Notice NOT-AI-21-038 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Administrative Supplements for Equipment Purchases for NIGMS-funded Center and Core Facilities
Notice NOT-GM-21-029 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Participation for RFA-MH-20-620, "BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)"
Notice NOT-MH-21-200 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed)
Funding Opportunity RFA-DE-22-001 from the NIH Guide for Grants and Contracts. The objective of the NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) is to provide longer-term support to NIDCR-funded investigators, who are in their mid-career stage, and have outstanding records of research productivity, mentorship and professional service to the research community. It is expected that the SOAR Award will propel the investigator along this career trajectory and allow him/her to embark on ambitious longer-term projects of extraordinary potential within the mission of NIDCR.
Categories: Job Watch, Literature Watch
NINDS Institutional Research Training Program (T32 - Clinical Trial Not Allowed)
Funding Opportunity PAR-21-149 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to provide support for institutional research training programs in areas relevant to the NINDS mission. These institutional research training programs should produce well-trained neuroscientists who leave the program with the research skills and scientific knowledge to make a significant contribution to neuroscience research. Programs should be designed to enhance the breadth and depth of training in NINDS mission areas by incorporating didactic, research and career development components in the context of a defined scientific theme. Programs may support basic, clinical and/or translational research. Critical components of programs supported by this FOA include mechanisms to ensure a thorough understanding of experimental design, strong statistics and analytical skills, and skills for communicating science, both orally and in writing, to a wide variety of audiences. Regardless of theme, programs should provide opportunities and activities that will foster the development of quantitative literacy and the application of quantitative approaches to the trainees' research. NINDS institutional training programs are intended to be 1-2 years in duration and support training of one or more of the following groups: dissertation stage predoctoral students in their 3rd and/or 4th year of graduate school, postdoctoral fellows and fellowship-stage clinicians. (NINDS does not support first or second year graduate students under this PAR).
Categories: Job Watch, Literature Watch
Notice of National Institute on Alcohol Abuse and Alcoholism (NIAAA) Participation in PAR-21-145, Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed)
Notice NOT-AA-21-007 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NEI Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
Notice NOT-EY-21-008 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of National Institute on Alcohol Abuse and Alcoholism (NIAAA) Participation in PAR-21-144, Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 BESH Required)"
Notice NOT-AA-21-006 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Expiration of RFA-RM-20-023 "NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed)"
Notice NOT-RM-21-018 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch